标题
HER2 Expression in Ovarian Mucinous Carcinomas in Tunisia
作者
关键词
-
出版物
Asian Pacific Journal of Cancer Prevention
Volume 15, Issue 19, Pages 8121-8125
出版商
Asian Pacific Organization for Cancer Prevention
发表日期
2014-12-19
DOI
10.7314/apjcp.2014.15.19.8121
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Determination of HER2 Gene Amplification in Breast Cancer using Dual-color Silver Enhanced in situ Hybridization (dc-SISH) and Comparison with Fluorescence ISH (FISH)
- (2014) Betul Unal et al. Asian Pacific Journal of Cancer Prevention
- Detection of HER2 Status in Breast Cancer: Comparison of Current Methods with MLPA and Real-time RT-PCR
- (2014) Reza Pazhoomand et al. Asian Pacific Journal of Cancer Prevention
- Association of High LDH and Low Glucose Levels in Pleural Space with HER2 Expression in Non-Small Cell Lung Cancer
- (2014) Bijan Ziaian et al. Asian Pacific Journal of Cancer Prevention
- Retrospective Analysis of Neoadjuvant Chemotherapy for Breast Cancer in Turkish Patients
- (2013) Berna Bozkurt Duman et al. Asian Pacific Journal of Cancer Prevention
- Impact of HER2 and PTEN Simultaneous Deregulation in Non-small Cell Lung Carcinoma: Correlation with Biological Behavior
- (2013) Ioannis Panagiotou et al. Asian Pacific Journal of Cancer Prevention
- Adjuvant Trastuzumab for 6 Months is Effective in Patients with HER2-positive Stage II or III Breast Cancer
- (2013) Cheng-Jeng Tai et al. Asian Pacific Journal of Cancer Prevention
- HER2 Amplification and Clinicopathological Characteristics in a Large Asian Cohort of Rare Mucinous Ovarian Cancer
- (2013) Wen-Yee Chay et al. PLoS One
- HER2/neu Expression in Head and Neck Squamous Cell Carcinoma Patients is not Significantly Elevated
- (2012) Yasaman Sardari et al. Asian Pacific Journal of Cancer Prevention
- Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates
- (2012) Ananta Gurung et al. HISTOPATHOLOGY
- Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
- (2012) Michael S Anglesio et al. JOURNAL OF PATHOLOGY
- Identification of the Coexisting HER2 Gene Amplification and Novel Mutations in the HER2 Protein-Overexpressed Mucinous Epithelial Ovarian Cancer
- (2011) Wea-Lung Lin et al. ANNALS OF SURGICAL ONCOLOGY
- Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma
- (2011) S. John Weroha et al. GYNECOLOGIC ONCOLOGY
- Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation enables accurate assessment of HER2 genomic status in ovarian tumours
- (2011) B. Yan et al. JOURNAL OF CLINICAL PATHOLOGY
- Trends in the incidence of cancer in the Sousse region, Tunisia, 1993-2006
- (2010) Nabiha Missaoui et al. INTERNATIONAL JOURNAL OF CANCER
- HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
- (2009) Jessica N McAlpine et al. BMC CANCER
- Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer
- (2009) Peter J. Frederick et al. GYNECOLOGIC ONCOLOGY
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma
- (2008) Adelaida García-Velasco et al. Clinical & Translational Oncology
- Systematic Review of HER2 Breast Cancer Testing
- (2008) Marta Cuadros et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started